Should I keep taking avatrombopag maleate tablets?

Avatrombopag Maleate Tablets is a drug for the treatment of chronic immune thrombocytopenia (ITP). Its therapeutic effect usually needs to last for a period of time to reach its optimal state. Therefore, patients usually need to continue taking avatrombopag maleate tablets for a period of time after starting to use them, until the doctor makes a decision to adjust or discontinue the drug based on the patient's specific conditions. The following is relevant information on whether avatrombopag maleate tablets require continued use:

1. Determined based on the patient’s condition: The duration of use of avatrombopag maleate tablets depends on the patient’s condition and treatment response. For some patients with ITP long-term or continued use of this drug may be needed to maintain stable platelet numbers and reduce the risk of bleeding. However, for other patients, a shorter treatment period may be enough to achieve the desired effect, after which the doctor may consider reducing the dose or discontinuing the medication.

2. Long-term maintenance treatment: For some patients with ITP , especially those whose platelet counts persist below the normal range or are prone to relapse, avatropopag maleate tablets may need to be used as part of long-term maintenance treatment. Continued use of the medication can help keep platelet counts stable, reduce the risk of bleeding, and improve quality of life.

3. Regular evaluation and adjustment: During the use of avatrombopag maleate tablets, patients need to receive regular evaluation and monitoring from their doctor. Doctors will evaluate the patient based on factors such as platelet count, symptoms, and drug tolerance, and adjust drug dosage or continue the original treatment plan as needed.

4. Gradually reduce the dose or discontinue the drug: After the patient's condition stabilizes and the treatment goals set by the doctor are achieved, the doctor may consider gradually reducing the dose of avatrombopag maleate tablets or discontinuing the drug. This is usually done when the doctor confirms that the patient's condition is well controlled, their platelet count is stable, and they do not require long-term dependence on medications.

In short, the duration of use of avatrombopag maleate tablets should be determined according to the patient's condition and treatment response, and needs to be evaluated and adjusted under the guidance of a doctor. Patients should always follow their doctor's advice and seek prompt medical treatment.